ABSTRACT

Objective:

In this study, it was aimed to retrospectively evaluate the anti-Toxoplasma IgG, IgM and avidity index results of patients who were requested for Toxoplasma serology in our hospital between 01.01.2017 and 31.12.2021.

Methods:

Anti-Toxoplasma antibodies are studied with Abbott Architect İ2000 SR device that using the chemiluminescent microparticle immunoassay method (CMIA), according to the company's recommendations. The age, gender, nationality, sending clinic/polyclinic, and pregnancy status information of patients were scanned from the hospital system.

Results:

In the five-year period between 2017 and 2021, 29.58% of anti-Toxoplasma IgG tests requested from 12694 patients and 0.94% of anti-Toxoplasma IgM tests sent from 12546 patients were found positive. It is striking that the number of test requests is higher in women. IgG positivity is highest in women in the age group of 30-39 (9.97%), and in men in the age group of 60-69 (6.97%). IgM positivity is higher in both women and men in the 20-29 age group (0.48% and 0.38%, respectively). Anti-Toxoplasma IgG was positive in 27.78% and IgM in 0.64% of the pregnant women. IgG positivity in Turkish and Syrian pregnant women were determined as 25.88%; 47.10% and IgM positivity as 0.49% and 1.83%, respectively, and the difference was statistically significant (p<0.001).

Conclusion:

Our anti-Toxoplasma antibody positivity was found to be compatible with studies conducted in different centers in our country. The fact that IgM positivity in women is high in the 20-29 age group, which is the childbearing age, emphasizes the importance of screening before and during pregnancy. Consistent with other studies in the literature, the rate of seropositivity in Syrian pregnant women was found to be higher than Turkish. This is important in terms of showing the effect of socio-cultural behaviors on prevalence.

Keywords: Toxoplasma, serology, antibody, prevalence, pregnant

References

Matta SK, Rinkenberger N, Dunay IR, Sibley LD. Toxoplasma gondii infection and its implications within the central nervous system. Nat Rev Microbiol 2021; 19: 467-80.

Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-58.

Montoya J, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76.

Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol 2009; 39: 895-901.

Swisher CN, Boyer K, McLeod R. Congenital toxoplasmosis. The Toxoplasmosis Study Group. Semin Pediatr Neurol 1994; 1: 4-25.

Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician 2014; 60: 334-6.

McAuley JB. Congenital toxoplasmosis. J Pediatr Infect Dis Soc 2014; 3: 30-5.

Berthélémy S. Toxoplasmose et grossesse. Actualités Pharmaceutiques 2014; 53: 43-5.

Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites Vectors 2015; 8: 292.

Switaj K, Master A, Skrzypczak M, Zaborowski P. Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin Microbiol Infect 2005; 11: 170-6.

Montoya JG, Rosso F. Diagnosis and management of toxoplasmosis. Clin Perinatol 2005; 32: 705-26.

Candolfi E, Pastor R, Huber R, Filisetti D, Villard O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis 2007; 58: 83-8.

Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation Epidemiol Infect 2014; 142: 1661-70.

Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford) 2015; 54: 1939-40.

Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed 2019; 36: 898-925.

Alver O, Payaslıoğlu M, Ener B. Investigation of Toxoplasma gondii Seropositivity in Uludağ University Hospital between 2009-2016. Turkiye Parazitol Derg 2019; 43: 8-12.

Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009; 39: 1385-94.

Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg 2014; 90: 794-9.

Yousefvand A, Mirhosseini SA, Ghorbani M, Mohammadzadeh T, Moosazadeh Moghaddam M, Mohammadyari S. Molecular and serological detection and of Toxoplasma gondii in small ruminants of southwest Iran and the potential risks for consumers. J Verbrauch Lebensm 2021; 16: 117-27.

Borkakoty B, Biswas D, Jakharia A, Mahanta J. Seroprevalence of Toxoplasma gondii among pregnant women in Northeast India. J Assoc Physicians India 2016; 64: 24-8.

Malatyalı E, Yıldız İ, Tileklioğlu E, Ertabaklar H, Ertuğ S. Retrospective Analysis of Toxoplasma gondii Serology Results from Adnan Menderes University Faculty of Medicine Parasitology Laboratory from 2007 to 2017. Turkiye Parazitol Derg 2019; 43: 1-4.

Tekay F, Ozbek E. [The seroprevalence of Toxoplasma gondii in women from Sanliurfa, a province with a high raw meatball consumption]. Turkiye Parazitol Derg 2007; 31: 176-9.

Hökelek M, Uyar Y, Günaydın M, Çetin M. Toxoplasma antikorlarının Samsun yöresinde seroprevalansının araştırılması. Ondokuz Mayıs Üniversitesi Tıp Dergisi 2000; 17: 50-5.

Babür C, Yücesan B, Sezen F, Kılıç S. Ulusal Parazitoloji Evaluation of Seropositivity of Toxoplasmosis Suspected Patients Admitted to the National Parasitology Reference Laboratory Between 2009 and 2019. Turkiye Parazitol Derg 2021; 45: 181-9.

Kuk S, Özden M. Hastanemizde dört yıllık Toxoplasma gondii seropozitifliğinin araştırılması. Turkiye Parazitol Derg 2007; 31: 1-3.

Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, et al. Serological Diagnosis of Toxoplasma gondii Infection: Recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 2016; 84: 22-3.

Türk M, Güngör S, Bayram D, Bilgin N, Er H, Kurultay N, ve ark. İzmir Atatürk Eğitim ve Araştırma Hastanesine Bir Yılda Başvuran Toxoplasmosis şüpheli hastaların ELISA yöntemiyle taranması. Türkiye Parazitol Derg 2004; 28: 80-2.

Pektaş B, Aksoy Gökmen A, Er HH, Güngör S, Kaya S, Demirci M. Evaluation of Serological Results of Patients with Suspected Toxoplasmosis. Turkiye Parazitol Derg 2015; 39: 90-3.

Bigna JJ, Tochie JN, Tounouga DN, Olive Bekolo A, Ymele NS, Youda EL, et al. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Sci Rep 2020; 10.

Kasap B, Öner G, Küçük M, Öztürk Turhan N, Akın MN, Arıkan S, et al. Evaluation of toxoplasmosis, rubella, cytomegalovirus and hepatitis prevalence of pregnant women in Muğla. Tepecik Eğit ve Araşt Hast Derg 2017; 27: 31-6.

Altunal LN, Esen AB, Karagöz G, Kart Yaşar K. Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus Among Pregnant Refugees and Turkish Women: A Retrospective Comparative Study. South Clin Ist Euras 2018; 29: 235-9.

Mumcuoglu I, Toyran A, Cetin F, Coskun FA, Baran I, Aksu N, et al. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm]. Mikrobiyol Bul 2014; 48: 283-91.

Hansu K, Özdemir H, Hansu İ, Çıkım G, Tok A. Comparison of the Toxoplasma Seroprevalence Rates in Syrian Refugee Pregnant Women and Turkish Pregnant Women. Turkiye Parazitol Derg 2021; 45: 247-51.

Bakacak M, Serin S, Aral M, Ercan Ö, Köstü B, Kireçci A, et al. [Seroprevalance Differences of Toxoplasma Between Syrian Refugees Pregnants and Indigenous Turkish Pregnants in Kahramanmaraş]. Turkiye Parazitol Derg 2015; 39: 94-7.

Kul G, Turan G. Comparison of Toxoplasma and Rubella seropositivity rates of Syrian and Turkish pregnant women. Cukurova Med J 2021; 46: 975-81.

Retrospective Evaluation of Toxoplasma Serology in Patients Admitted to a Training and Research Hospital Between 2017-2021

ABSTRACT

References